Bicycle Therapeutics plc Depreciation
Bicycle Therapeutics plc (BCYC) reported Depreciation of $1.60 million for the 3-month period ending 2024-06-30, per its 10-Q filed 2024-08-06.
Discontinued › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2024-08-06
- Bicycle Therapeutics plc depreciation for the quarter ending 2024-06-30 was $1.60M, a 0.00% change year-over-year.
- Bicycle Therapeutics plc depreciation for the quarter ending 2024-03-31 was $1.70M, a 6.25% increase year-over-year.
- Bicycle Therapeutics plc depreciation for the quarter ending 2023-12-31 was $1.60M, a 6.67% increase year-over-year.
- Bicycle Therapeutics plc depreciation for the quarter ending 2023-09-30 was $1.70M, a 30.77% increase year-over-year.
- Bicycle Therapeutics plc depreciation for fiscal 2023 was $6.50M, a 75.68% increase from fiscal 2022.
- Bicycle Therapeutics plc depreciation for fiscal 2022 was $3.70M, a 164.29% increase from fiscal 2021.
- Bicycle Therapeutics plc depreciation for fiscal 2021 was $1.40M, a 7.69% increase from fiscal 2020.
- Bicycle Therapeutics plc depreciation for fiscal 2020 was $1.30M, a 30.00% increase from fiscal 2019.
| Period end | Depreciation 3 month | Depreciation 3 month as first filed | Depreciation 6 month | Depreciation 6 month as first filed | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|---|---|---|
| 2024-06-30 | $1.60M 10-Q · filed 2024-08-06 | $3.30M 10-Q · filed 2024-08-06 | $4.90M derived: sum of 3 quarters · filed 2024-08-06 | $6.60M derived: sum of 4 quarters · filed 2024-08-06 | ||
| 2024-03-31 | $1.70M 10-Q · filed 2024-05-02 | $3.30M derived: sum of 2 quarters · filed 2024-05-02 | $5.00M derived: sum of 3 quarters · filed 2024-05-02 | $6.60M derived: sum of 4 quarters · filed 2024-08-06 | ||
| 2023-12-31 | $1.60M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | $3.30M derived: sum of 2 quarters · filed 2024-02-20 | $4.90M derived: sum of 3 quarters · filed 2024-08-06 | $6.50M 10-K · filed 2024-02-20 | ||
| 2023-09-30 | $1.70M 10-Q · filed 2023-11-02 | $3.30M derived: sum of 2 quarters · filed 2024-08-06 | $4.90M 10-Q · filed 2023-11-02 | $6.40M derived: sum of 4 quarters · filed 2024-08-06 | ||
| 2023-06-30 | $1.60M 10-Q · filed 2024-08-06 | $3.20M 10-Q · filed 2024-08-06 | $4.70M derived: sum of 3 quarters · filed 2024-08-06 | $6.00M derived: sum of 4 quarters · filed 2024-08-06 | ||
| 2023-03-31 | $1.60M 10-Q · filed 2024-05-02 | $3.10M derived: sum of 2 quarters · filed 2024-05-02 | $4.40M derived: sum of 3 quarters · filed 2024-05-02 | $5.00M derived: sum of 4 quarters · filed 2024-05-02 | ||
| 2022-12-31 | $1.50M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | $2.80M derived: sum of 2 quarters · filed 2024-02-20 | $3.40M derived: sum of 3 quarters · filed 2024-02-20 | $3.70M 10-K · filed 2024-02-20 | ||
| 2022-09-30 | $1.30M 10-Q · filed 2023-11-02 | $1.90M derived: sum of 2 quarters · filed 2023-11-02 | $2.20M 10-Q · filed 2023-11-02 | $2.70M derived: sum of 4 quarters · filed 2024-02-20 | ||
| 2022-06-30 | $600.00K 10-Q · filed 2023-08-03 | $1.00M 10-Q · filed 2023-08-03 | $1.40M derived: sum of 3 quarters · filed 2024-02-20 | $1.70M derived: sum of 4 quarters · filed 2024-02-20 | ||
| 2022-03-31 | $400.00K 10-Q · filed 2023-05-04 | $800.00K derived: sum of 2 quarters · filed 2024-02-20 | $1.10M derived: sum of 3 quarters · filed 2024-02-20 | $1.40M derived: sum of 4 quarters · filed 2024-02-20 | ||
| 2021-12-31 | $400.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | $700.00K derived: sum of 2 quarters · filed 2024-02-20 | $1.00M derived: sum of 3 quarters · filed 2024-02-20 | $1.40M 10-K · filed 2024-02-20 | ||
| 2021-09-30 | $300.00K 10-Q · filed 2022-11-03 | $600.00K derived: sum of 2 quarters · filed 2022-11-03 | $1.00M 10-Q · filed 2022-11-03 | $1.30M derived: sum of 4 quarters · filed 2023-02-28 | ||
| 2021-06-30 | $300.00K 10-Q · filed 2022-08-04 | $700.00K 10-Q · filed 2022-08-04 | $1.00M derived: sum of 3 quarters · filed 2023-02-28 | $1.30M derived: sum of 4 quarters · filed 2023-02-28 | ||
| 2021-03-31 | $300.00K 10-Q · filed 2022-05-05 | $700.00K derived: sum of 2 quarters · filed 2023-02-28 | $1.00M derived: sum of 3 quarters · filed 2023-02-28 | $1.30M derived: sum of 4 quarters · filed 2023-02-28 | ||
| 2020-12-31 | $400.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $700.00K derived: sum of 2 quarters · filed 2023-02-28 | $1.00M derived: sum of 3 quarters · filed 2023-02-28 | $1.30M 10-K · filed 2023-02-28 | ||
| 2020-09-30 | $300.00K 10-Q · filed 2021-11-04 | $600.00K derived: sum of 2 quarters · filed 2021-11-04 | $900.00K 10-Q · filed 2021-11-04 | $1.20M derived: sum of 4 quarters · filed 2022-03-01 | ||
| 2020-06-30 | $300.00K 10-Q · filed 2021-08-05 | $600.00K 10-Q · filed 2021-08-05 | $200.00K 10-Q · filed 2020-08-05 | $900.00K derived: sum of 3 quarters · filed 2022-03-01 | $1.10M derived: sum of 4 quarters · filed 2022-03-01 | |
| 2020-03-31 | $300.00K 10-Q · filed 2021-05-06 | $600.00K derived: sum of 2 quarters · filed 2022-03-01 | $800.00K derived: sum of 3 quarters · filed 2022-03-01 | $1.40M derived: sum of 4 quarters · filed 2022-03-01 | ||
| 2019-12-31 | $300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $500.00K derived: sum of 2 quarters · filed 2022-03-01 | $1.10M derived: sum of 3 quarters · filed 2022-03-01 | $1.00M 10-K · filed 2022-03-01 | ||
| 2019-09-30 | $200.00K 10-Q · filed 2020-11-05 | $800.00K derived: sum of 2 quarters · filed 2020-11-05 | $700.00K 10-Q · filed 2020-11-05 | $1.20M derived: sum of 4 quarters · filed 2021-03-11 | ||
| 2019-06-30 | $600.00K 10-Q · filed 2020-08-05 | $200.00K 10-Q · filed 2019-08-08 | $400.00K 10-Q · filed 2020-08-05 | $1.00M derived: sum of 3 quarters · filed 2021-03-11 | $1.20M derived: sum of 4 quarters · filed 2021-03-11 | |
| 2019-03-31 | $200.00K 10-Q · filed 2020-05-07 | $400.00K derived: sum of 2 quarters · filed 2021-03-11 | $600.00K derived: sum of 3 quarters · filed 2021-03-11 | $800.00K derived: sum of 4 quarters · filed 2021-03-11 | ||
| 2018-12-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $400.00K derived: sum of 2 quarters · filed 2021-03-11 | $600.00K derived: sum of 3 quarters · filed 2021-03-11 | $700.00K 10-K · filed 2021-03-11 | ||
| 2018-09-30 | $200.00K 10-Q · filed 2019-11-07 | $400.00K derived: sum of 2 quarters · filed 2019-11-07 | $500.00K 10-Q · filed 2019-11-07 | |||
| 2018-06-30 | $200.00K 10-Q · filed 2019-08-08 | $400.00K 10-Q · filed 2019-08-08 | ||||
| 2017-12-31 | $300.00K 10-K · filed 2020-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B |